Skip to main content
OpenTrials
Completed

NCT Number: NCT03364842

Furosemide and Coarctation Surgery Lung Complications

in our study the investigators give furosemide during surgery for repair of aortic coarctation via lateral thoracotomy and evaluated lung complications in comparison to control group

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pulmonary Complication

Age range

1 month–18 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Cairo university

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • coarctation of aorta

Exclusion criteria

  • heart failure, bleeding diathesis, associated cardiac congenital anomalies

Treatment and study plan

Furosemide

Drug

Administering furosemide

Primary outcomes

  1. lung ultrasonography scale > 24

    Time frame: a 1 year study

Secondary outcomes

  1. Pao2/ Fio2 ratio

    Time frame: a 1 year study

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Furosemide: Would it Help to Improve the Lungs During Aortic Coarctation Surgery

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Dec 7, 2017
Registry last updated
Dec 27, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.